Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35413124

Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Mol Cancer Ther
Publication date
2022 Jun 1
First author
Adashek JJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Adashek JJ
      type
      Author
    2. name
      Menta AK
      type
      Author
    3. name
      Reddy NK
      type
      Author
    4. name
      Desai AP
      type
      Author
    5. name
      Roszik J
      type
      Author
    6. name
      Subbiah V
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Adashek JJ
      type
      Author
    2. name
      Menta AK
      type
      Author
    3. name
      Reddy NK
      type
      Author
    4. name
      Desai AP
      type
      Author
    5. name
      Roszik J
      type
      Author
    6. name
      Subbiah V
      type
      Author
    bibliography ids
    1. nci-bib-25565f2ac3b6acfe2eb6be41
    book metadata
    content sha256
    f50a92c4d59be6674735076ff7f74c1110f697546f4f19e096acd49538220461
    document type
    citation
    dois
    1. 10.1158/1535-7163.MCT-21-0950
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35413124
    immutable id
    pubmed:35413124@f50a92c4d59be6674735076ff7f74c1110f697546f4f19e096acd49538220461
    journal
    abbreviation
    Mol Cancer Ther
    issn electronic
    1538-8514
    issn print
    1535-7163
    issue
    6
    name
    Molecular cancer therapeutics
    nlm unique id
    101132535
    pages
    871-878
    volume
    21
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35413124
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      d2369643621b896a3979540737943b874fb6ea3b4afe0bd456d9fa2ccb730c3c
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Jun 1
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      2. Review
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35413124/
      title
      Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant Tumors.

      Preserved source evidence · Not medical advice